Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Brain : a Journal of Neurology
|
February 18, 2020
Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau
Edward N Wilson, Michelle S Swarovski, Patricia Linortner, et al.
Annals of Neurology
|
June 18, 2024
Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease
Carla Abdelnour, Christina B Young, Marian Shahid-Besanti, et al.
Acta Neuropathologica
|
March 12, 2024
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease
Jarod Rutledge, Benoit Lehallier, Pardis Zarifkar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Alena Marie Smith, Sara A Lorkiewicz, Laia Montoliu-Gaya, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 3, 2026
Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
Joseph R Winer, Melanie J Plastini, America Romero, et al.
Research Square
|
October 14, 2024
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Edward Wilson, Jacob Umans, Michelle Swarovski, et al.
NPJ Parkinson'S Disease
|
April 10, 2026
Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease
Alena M Smith, Sara A Lorkiewicz, Burak Arslan, et al.
NPJ Parkinson'S Disease
|
April 26, 2025
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Edward N Wilson, Jacob Umans, Michelle S Swarovski, et al.
Alzheimer'S Research & Therapy
|
November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease
Edward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2024
Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum
Alexandra N Trelle, Christina B Young, Hillary Vossler, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Brain : a Journal of Neurology
|
February 18, 2020
Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau
Edward N Wilson, Michelle S Swarovski, Patricia Linortner, et al.
Annals of Neurology
|
June 18, 2024
Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease
Carla Abdelnour, Christina B Young, Marian Shahid-Besanti, et al.
Acta Neuropathologica
|
March 12, 2024
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease
Jarod Rutledge, Benoit Lehallier, Pardis Zarifkar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Alena Marie Smith, Sara A Lorkiewicz, Laia Montoliu-Gaya, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 3, 2026
Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
Joseph R Winer, Melanie J Plastini, America Romero, et al.
Research Square
|
October 14, 2024
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Edward Wilson, Jacob Umans, Michelle Swarovski, et al.
NPJ Parkinson'S Disease
|
April 10, 2026
Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease
Alena M Smith, Sara A Lorkiewicz, Burak Arslan, et al.
NPJ Parkinson'S Disease
|
April 26, 2025
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Edward N Wilson, Jacob Umans, Michelle S Swarovski, et al.
Alzheimer'S Research & Therapy
|
November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease
Edward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2024
Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum
Alexandra N Trelle, Christina B Young, Hillary Vossler, et al.
Page
of 3